-
Trasylol already carries a "black box" on its labeling, which warns doctors that it can cause kidney problems.
FORBES: Bayer's Big Mistake
-
Or at Bayer, which will face another FDA panel about the risks of it heart surgery drug Trasylol Wednesday.
FORBES: Magazine Article
-
In a prepared statement, Bayer said that it remains committed to patient safety and to evaluating the safety and efficacy of Trasylol.
FORBES: Magazine Article
-
On Sept. 21, the FDA's panel of medical experts met to consider that data and voted 18 to 0 that Trasylol did not need new safety labeling.
FORBES: Bayer's Big Mistake
-
According to a Public Health Advisory from the FDA, the new study linked Trasylol to increased risk of death, serious kidney damage, congestive heart failure and strokes.
FORBES: Bayer's Big Mistake
-
Or at Bayer (nyse: BAY - news - people ), which will face another FDA panel about the risks of it heart surgery drug Trasylol Wednesday.
FORBES: Obesity Pill Faces Long Wait
-
This year, the company has faced controversy over its drug Trasylol, used in heart surgery, which a study in The New England Journal of Medicine said may pose significant risks to patients.
FORBES: Avaricious In Germany
-
Bayer said in a statement that it "mistakenly" did not tell the FDA about the evaluation of 67, 000 hospital records regarding the drug Trasylol, which is used to prevent bleeding during open-heart surgery.
FORBES: Magazine Article
-
Bayer (nyse: BAY - news - people ) said in a statement that it "mistakenly" did not tell the FDA about the evaluation of 67, 000 hospital records regarding the drug Trasylol, which is used to prevent bleeding during open-heart surgery.
FORBES: Bayer's Big Mistake